The Valley Desk

NCT04752826 · Interventional trial

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

Overall registry status Recruiting

Phase 1 · Phase 2

Conditions Advanced Malignancies, Melanoma, Ovarian Cancer, T-cell Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov